CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $173,486 | -15.1% | 133,451 | -0.1% | 0.00% | – |
Q1 2024 | $204,309 | +90.3% | 133,535 | +45.5% | 0.00% | – |
Q4 2023 | $107,379 | +30.2% | 91,777 | -3.2% | 0.00% | – |
Q3 2023 | $82,452 | -23.3% | 94,783 | -1.2% | 0.00% | – |
Q2 2023 | $107,492 | +7.2% | 95,975 | -0.4% | 0.00% | – |
Q1 2023 | $100,226 | +0.6% | 96,371 | +8.3% | 0.00% | – |
Q4 2022 | $99,636 | -1.4% | 88,961 | 0.0% | 0.00% | – |
Q3 2022 | $101,000 | -22.9% | 88,961 | 0.0% | 0.00% | – |
Q2 2022 | $131,000 | -41.0% | 88,961 | -8.1% | 0.00% | – |
Q1 2022 | $222,000 | -16.5% | 96,806 | +0.0% | 0.00% | – |
Q4 2021 | $266,000 | -57.0% | 96,786 | -6.2% | 0.00% | – |
Q3 2021 | $619,000 | +44.6% | 103,223 | +17.6% | 0.00% | – |
Q2 2021 | $428,000 | +97.2% | 87,806 | 0.0% | 0.00% | – |
Q1 2021 | $217,000 | -4.8% | 87,806 | +5.4% | 0.00% | – |
Q4 2020 | $228,000 | +81.0% | 83,342 | +1.8% | 0.00% | – |
Q3 2020 | $126,000 | -25.4% | 81,842 | -8.9% | 0.00% | – |
Q2 2020 | $169,000 | +11.9% | 89,809 | +1.1% | 0.00% | – |
Q1 2020 | $151,000 | -24.5% | 88,838 | +28.9% | 0.00% | – |
Q4 2019 | $200,000 | +412.8% | 68,927 | +11.2% | 0.00% | – |
Q3 2019 | $39,000 | -86.4% | 61,997 | -79.0% | 0.00% | – |
Q2 2019 | $287,000 | -33.9% | 295,392 | -6.0% | 0.00% | – |
Q1 2019 | $434,000 | +28.8% | 314,381 | -0.4% | 0.00% | – |
Q4 2018 | $337,000 | -82.7% | 315,578 | -0.3% | 0.00% | – |
Q3 2018 | $1,946,000 | -41.6% | 316,437 | +1.5% | 0.00% | -100.0% |
Q2 2018 | $3,333,000 | +27.7% | 311,755 | +28.1% | 0.00% | 0.0% |
Q1 2018 | $2,611,000 | +66.6% | 243,398 | +8.7% | 0.00% | – |
Q4 2017 | $1,567,000 | -20.7% | 223,922 | -1.0% | 0.00% | -100.0% |
Q3 2017 | $1,977,000 | -2.0% | 226,195 | +2.1% | 0.00% | 0.0% |
Q2 2017 | $2,018,000 | +123.5% | 221,468 | +94.8% | 0.00% | – |
Q1 2017 | $903,000 | +10.4% | 113,714 | +24.2% | 0.00% | – |
Q4 2016 | $818,000 | – | 91,540 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 2,458,600 | $5,630,000 | 5.96% |
Carmignac Gestion | 2,485,652 | $5,692,000 | 0.09% |
XTX Topco Ltd | 50,947 | $117,000 | 0.05% |
Golden State Equity Partners | 31,327 | $72,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 78,274 | $179,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $725,000 | 0.01% |
Newman Dignan & Sheerar, Inc. | 27,023 | $62,000 | 0.01% |
Curi Wealth Management, LLC | 25,000 | $57,000 | 0.01% |
Northeast Financial Consultants Inc | 53,000 | $121,000 | 0.01% |
Assenagon Asset Management S.A. | 913,789 | $2,093,000 | 0.01% |